|
Senior Director, Toxicology Alnylam was founded in 2002 on a revolutionary vision and bold mission which remain firmly in place today. We are leading the translation of RNAi as a new class of medicines with a core focus on RNAi therapeutics toward genetically defined targets for the treatment of serious, life-threatening diseases with limited treatment options for patients and their caregivers. In January 2015, we announced our "Alnylam 2020" guidance that reflects our expected transition from a late-stage clinical. After registering you may be able to apply for this job directly (if still active) on (Alnylam Pharmaceuticals, Inc.)'s site. Future job matches may be sent from Geebo approved job partners.
|